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a b s t r a c t
The inositol 1,4,5-triphosphate receptor type 1 (ITPR1) gene on chromosome 3 belongs to a
family of genes encoding intracellular calcium channel proteins. Such channels are located
primarily within the endoplasmic reticular membrane and release Ca2+, an intracellular
messenger, which governs numerous intracellular and extracellular functions.
We report a family with infantile-onset cerebellar ataxia with delayed motor develop-
ment and intellectual disability caused by a heterozygous c.805C>T, p.Arg269Trp missense
mutation in ITPR1. Both affected family members had postural tremor, hypotonia and
dysarthria, but neither had pyramidal signs. Their neuroimaging revealed cerebellar atro-
phy.
Several neurological conditions have been associated with ITPR1 mutations, such as
spinocerebellar ataxia type 15 and Gillespie syndrome, and the phenotype may vary
according to the location and type of mutations. Spinocerebellar ataxia type 15 is an
autosomal dominant disorder, which causes late onset pure cerebellar ataxia. Gillespie
syndrome is characterised by bilateral iris hypoplasia, congenital hypotonia, non-progres-
sive ataxia and cerebellar atrophy.
In this report, we provide a detailed phenotypic description of a family with a missense
mutation in ITPR1. This mutation has only been reported once before. We also provide a
literature review of the various phenotypes associated with ITPR1 gene.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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The inositol 1,4,5-triphosphate receptor type 1 (ITPR1) gene
belongs to a family of genes (type 1, 2 and 3) that encode for the
intracellular calcium channels. Such channels are located
primarily within the endoplasmic reticular membrane and
release Ca2+, an intracellular messenger that governs numer-
ous intracellular and extracellular functions. ITPR1 is ubiqui-
tously expressed throughout the body and particularly in
cerebellar Purkinje cells [1]. It is hypothesised that the
impairment of the calcium buffering leads to Purkinje
dysfunction and therefore, the disruption of ITPR1-dependent
signalling plays a key role in the development of various forms
of cerebellar ataxias [2].
Functionally active ITPR1 is thought to form a homote-
tramer. Each monomer consists of a N-terminal inositol
triphosphate (InsP3) binding domain, a regulatory/coupling
domain and a C-terminal transmembrane domain with
relatively short cytoplasmic tail (Fig. 1A) [1]. The phenotype
associated with ITPR1 mutations may vary according to the
location and type of mutation present.
In this report, we provide a detailed phenotypic description
of a family with a missense mutation in ITPR1 and a literature
review of the various phenotypes associated with mutations in
this gene.Fig. 1 – (A) Schematic representation of the ITPR1 protein.
(B) Pedigree structure. (C) MRI head of the mother showing
cerebellar atrophy. (D) Amino acid sequence of the
mutation site is conserved in many species.2. Case description
Patient A (see Fig. 1B, arrowed) was referred to a paediatrician
at the age of 27 months with developmental delay. She was
diagnosed with 'ataxic cerebral palsy'. She was able to walk
unsupported at the age of 9 years and attended a school for
children with special needs between the age of 3 and 16 years.
Patient A came to our attention in her 30 s after further
deterioration in her gait, as the requirement to use a walking
aid became evident. At that time examination revealed
postural tremor, hypotonia, limb ataxia and cerebellar dysar-
thria. There was no nystagmus, but she had broken smooth
pursuit eye movements and saccades in all directions were
slow.
Patient B, the daughter of Patient A, was hypotonic at birth,
crawled at the age of 3 years and was only able to walk small
distances with a wide-based gait before becoming wheelchair
bound in her childhood. In addition to her delayed motor
development, she exhibited intellectual disability and cere-
bellar signs (Supplementary Table 1). Neither exhibited any
pyramidal signs. Both had myoclonic jerks and myokymia
with normal serum voltage-gated potassium channel antibody
levels. The head MRI showed cerebellar atrophy involving the
superior vermis and adjacent superior cerebellar surface in
both affected individuals (Fig. 1C).
The pedigree was suggestive of an autosomal dominant
disorder (Fig. 1B). The proband was screened for inherited
ataxia using the 'Inherited Ataxias Next Generation Sequenc-
ing – 43 Gene Panel', previously described by Nemeth et al. [3].
This identiﬁed the c.805C>T, p.Arg269Trp (Transciption ID:
NM_001168272.1) variant in ITPR1 in heterozygous form.
Screening of other family members conﬁrmed segregation
in affected individuals. p.Arg269 is highly conserved across
species and lies within the InsP3 binding domain of the protein
(Fig. 1D). Recently this mutation has been reported in
association with an autosomal dominant non-progressive
congenital ataxia in another family [4].
3. ITPR1 mutations: a detailed review of the
literature
Eleven different heterozygous missense mutations in ITPR1,
including the p.Arg269Trp mutation described here, have been
reported to cause a non-progressive infantile-onset cerebellar
ataxia and delayed motor development. This 'ataxic cerebral
palsy' phenotype is also known as spinocerebellar ataxia (SCA)
29 [4–11]. The cerebellar dysfunction may become apparent as
early as the ﬁrst day of life and generally within the ﬁrst year.
Common cerebellar features include nystagmus, ataxia,
postural tremor, dysarthria and hypotonia. The delayed motor
development and the absence of pyramidal dysfunction are
the hallmarks of this phenotype (Supplementary Table 1).
Overall, about 75% of individuals with SCA 29 exhibit
learning difﬁculties (Supplementary Table 1). Both affected
individuals that described here had intellectual difﬁculties.
However, this was only evident in one of the three affected
individuals of the second family with the same mutation [4].
Also all 20 affected individuals in the Australian family with
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NM_001099952.2) mutation had intellectual disability, com-
pared to none of the affected Russian family members with
this mutation [8,10,11]. Interestingly, a 45-year-old female
with heterozygous c.722G>A, p.Arg241Lys mutation did not
have pathogenic phenotype except incidental cerebellar
atrophy on neuroimaging, but her daughter had cerebellar
dysfunction and delayed motor development [4]. Therefore, it
is possible that some individuals with ITPR1 mutations may
not develop any symptoms.
SCA 15 and Gillespie syndrome (GS) are two other well-
known phenotypes associated with ITPR1 mutations. SCA 15,
an adult onset very slow progressive pure cerebellar ataxia, is
caused by heterozygous complete or partial deletions of ITPR1.
It typically presents with gait ataxia in the third decade of
life. The affected individuals remain ambulatory for several
decades after their diagnosis. Dysarthria, nystagmus, tremor
and relative absent pyramidal signs are other common
features of SCA 15. Unlike SCA 29 and GS, it is not typically
associated with delayed motor development or intellectual
disability. Twenty four families have been identiﬁed with this
phenotype so far [12–25].
The heterozygous deletion is proposed to cause haploin-
sufﬁciency. Interestingly, one heterozygous missense muta-
tion, c.8581C>T, p.Pro1059Leu (GenBank: AAB04947.2) in a
Japanese family has also been reported to cause this SCA 15
phenotype [15,16]. None of the affected members in this family
had delayed motor development or intellectual disability.
The p.Pro1059 residue is located in the regulatory/coupling
domain and has been found to increase the InsP3 ligand
binding afﬁnity without abolishing Ca2+ release in vitro [26].
The ligand binding to the InsP3 binding domain or the
regulatory/coupling domain modulates ITPR1 channel func-
tion by integrating other external signals [1]. Therefore, this
p.Pro1059Leu mutation is thought to inﬂuence channel gating
by altering its ligand binding properties. We hypothesise
that SCA 29 causing missense mutations located within the
InsP3 binding domain and the regulatory/coupling domain,
also impair the channel function by altering its ligand binding
properties.
GS is characterised by cerebellar ataxia, cerebellar atrophy,
aniridia, hypotonia, delayed motor developmental and intel-
lectual disability. It can be caused by homozygous partial
deletions, compound heterozygous truncating mutations or
heterozygous mutations located within the C-terminal trans-
membrane domain and its close vicinity (Supplementary
Table 2). The latter is thought to be dominant negative
mutation. These mutations have been proposed to abolish the
Ca2+ release property of the channel by disrupting its channel
pore structure [27,28].
In addition, there are two other lesser known phenotypes of
ITPR1 mutations, which are caused by mutations in the C-
terminal transmembrane domain. A heterozygous c.7568C>T,
p.Thr2523Met mutation has been reported to cause progres-
sive optic atrophy, ataxia, sensorineural hearing loss, muscle
weakness, vertigo, erythrocytosis and nystagmus [29]. Recent-
ly another heterozygous c.7649T>A, p.Ile2550Asn (mRNA
sequence: NM_001099952) mutation has been associated with
non-progressive early onset ataxia, hypotonia, hyperreﬂexia,
delayed motor development, intellectual disability and severepontocerebellar hypoplasia [30]. Unlike GS, neither of these
two mutations was associated with iris hypoplasia, despite
being located within the C-terminal transmembrane domain
of the protein. At this point it is difﬁcult to determine whether
these are incomplete variants of GS or completely new entities
and further analyses of these mutations are required.
4. Conclusions
We describe only the second reported case of a family with a
heterozygous c.805C>T, p.Arg269Trp mutation in ITPR1 pre-
senting with a ataxic cerebral palsy phenotype. Correlations
between the ITPR1 genotypes and phenotypes are increasingly
recognised. Although, the phenotypic variation appears to
depend on the site and nature of the mutation within the gene,
further studies are required to deﬁne the precise mechanism
of pathogenicity and associated variation in phenotype and
disease severity.
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